MegaMD Co. Ltd (133750) — Capital Reinvestment Ratio

Latest as of June 2025: 0.06x

MegaMD Co. Ltd (133750) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩2.56 Billion) in capital expenditures (₩161.10 Million). See debt-free asset ratio of MegaMD Co. Ltd to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.06x
Capex / Operating Cash Flow

Operating Cash Flow

₩2.56 Billion
KRW

Capital Expenditures

₩161.10 Million
KRW

Data as of

Jun 2025
Most recent filing

MegaMD Co. Ltd Capital Reinvestment Ratio (2014–2025)

This chart tracks MegaMD Co. Ltd's Capital Reinvestment Ratio across 11 annual periods. Check how aggressively does MegaMD Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for MegaMD Co. Ltd (2014–2025)

Year-by-year Capital Reinvestment Ratio for MegaMD Co. Ltd from 2014 to 2025. For live market cap and broader valuation context, see 133750 stock market capitalisation.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.26x ₩5.10 Billion ₩1.33 Billion ▲ +658.6%
2024 0.03x ₩8.39 Billion ₩288.61 Million ▼ -98.5%
2023 2.35x ₩1.05 Billion ₩2.48 Billion ▲ +1882.2%
2021 0.12x ₩17.94 Billion ₩2.13 Billion ▼ -12.0%
2020 0.13x ₩16.03 Billion ₩2.16 Billion ▼ -12.6%
2019 0.15x ₩9.69 Billion ₩1.50 Billion ▲ +5.3%
2018 0.15x ₩14.97 Billion ₩2.20 Billion ▼ -70.2%
2017 0.49x ₩7.60 Billion ₩3.74 Billion ▼ -77.3%
2016 2.16x ₩5.01 Billion ₩10.82 Billion ▲ +646.6%
2015 0.29x ₩18.12 Billion ₩5.25 Billion ▼ -35.6%
2014 0.45x ₩7.53 Billion ₩3.38 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow